Kodaganur S. Gopinath

Last updated

Kodaganur S. Gopinath
Born
Bangalore, Karnataka, India
SpouseKusum
ChildrenSrinivas
Sindhura
Awards Padma Shri
Dr. B. C. Roy Award
Rajoytsava Award
Association of Surgeons of India Award
Panchajanya Puraskara, 2013
Website Official web site of Ambuja Health Clinic

Dr. Kodaganur S. Gopinath, MS, FAMS, FRCS (Edin) is an Indian surgical oncologist, known for his pioneering work on oncological research. [1] He is a recipient of many awards including Dr. B. C. Roy Award, considered to be the premier medical honour in the country. [2] The President of India recognised his services to the field of oncology, by awarding him the fourth highest civilian award, Padma Shri, in 2010. [3]

Contents

Biography

I owe almost everything to my sister, Vimala," Dr Gopinath said on joining Kidwai Memorial Institute of Oncology , She supported me after my father. She had read about the vacancy in Kidwai and called me here [4]

Kodaganur S. Gopinath was born in Davangere, a small town in Karnataka and had humble beginnings. He had his early schooling at St Paul's Convent School and joined JJM Medical College, Davangere, in 1968, to secure his MBBS degree with third rank, in 1975. Higher studies in general surgery (MS) was done at the King Edward Memorial Hospital and Seth Gordhandas Sunderdas Medical College, Mumbai. [1] [4] Later, he obtained FRCS from the Royal College of Surgeons of Edinburgh and FAMS from the National Academy of Medical Sciences, New Delhi.

On his return from Edinburgh, Dr. Gopinath joined Kidwai Memorial Institute of Oncology, Bangalore as a surgical oncologist where he stayed till he started the work on the Bangalore Institute of Oncology in 1989. [4] He is the Director of Healthcare Global Enterprise (HCG), one of the world's largest cancer care providers [5] and the Director and Consultant Surgical Oncologist at the Bangalore Institute of Oncology and Ambuja Health Care. [4] [6]

Dr. Gopinath is married to a college lecturer, Kusum, and the couple has a son, Srinivas and a daughter, Sindhura. The family resides in Bangalore. [4] Srinivas is a Thoracic Oncology Fellow at Tata Memorial Centre in Mumbai and is recently married. Sindhura is pursuing her PhD in cancer biology at Icahn School of Medicine at Mount Sinai in New York City.

Legacy

Dr. Gopinath founded the Bangalore Institute of Oncology where he is working as the Director and Consultant Surgical Oncologist. [1] He is known to have done extensive research on oncology with special emphasis on the surgery of head and neck, comparative study of laparoscopic and conventional surgical methods, cancer of the rectum and the impact of yoga on cancer. [7] He is also regarded as a specialist in the treatment of breast cancer. [2]

Positions

Awards and recognitions

Publications

Dr. Gopinath has published several articles related to oncological studies. [8]

Related Research Articles

<span class="mw-page-title-main">Adenocarcinoma</span> Medical condition

Adenocarcinoma is a type of cancerous tumor that can occur in several parts of the body. It is defined as neoplasia of epithelial tissue that has glandular origin, glandular characteristics, or both. Adenocarcinomas are part of the larger grouping of carcinomas, but are also sometimes called by more precise terms omitting the word, where these exist. Thus invasive ductal carcinoma, the most common form of breast cancer, is adenocarcinoma but does not use the term in its name—however, esophageal adenocarcinoma does to distinguish it from the other common type of esophageal cancer, esophageal squamous cell carcinoma. Several of the most common forms of cancer are adenocarcinomas, and the various sorts of adenocarcinoma vary greatly in all their aspects, so that few useful generalizations can be made about them.

<span class="mw-page-title-main">Esophageal cancer</span> Gastrointestinal system cancer that is located in the esophagus

Esophageal cancer is cancer arising from the esophagus—the food pipe that runs between the throat and the stomach. Symptoms often include difficulty in swallowing and weight loss. Other symptoms may include pain when swallowing, a hoarse voice, enlarged lymph nodes ("glands") around the collarbone, a dry cough, and possibly coughing up or vomiting blood.

<span class="mw-page-title-main">Carcinoma</span> Malignancy that develops from epithelial cells

Carcinoma is a malignancy that develops from epithelial cells. Specifically, a carcinoma is a cancer that begins in a tissue that lines the inner or outer surfaces of the body, and that arises from cells originating in the endodermal, mesodermal or ectodermal germ layer during embryogenesis.

<span class="mw-page-title-main">Basal-cell carcinoma</span> Most common type of skin cancer

Basal-cell carcinoma (BCC), also known as basal-cell cancer, basalioma or rodent ulcer, is the most common type of skin cancer. It often appears as a painless raised area of skin, which may be shiny with small blood vessels running over it. It may also present as a raised area with ulceration. Basal-cell cancer grows slowly and can damage the tissue around it, but it is unlikely to spread to distant areas or result in death.

<span class="mw-page-title-main">Head and neck cancer</span> Cancer arises in the head or neck region

Head and neck cancer develops from tissues in the lip and oral cavity (mouth), larynx (throat), salivary glands, nose, sinuses, or skin of the face. The most common types of head and neck cancer occur in the lips, mouth, and larynx. Symptoms predominantly include a sore that does not heal or a change in the voice. In those with advanced disease, there may be unusual bleeding, facial pain, numbness or swelling, and visible lumps on the outside of the neck or oral cavity. Given the location of these cancers, it is possible for an afflicted individual to experience difficulty breathing.

Carcinoma <i>in situ</i> Pre-cancerous abnormal growth of tissue

Carcinoma in situ (CIS) is a group of abnormal cells. While they are a form of neoplasm, there is disagreement over whether CIS should be classified as cancer. This controversy also depends on the exact CIS in question. Some authors do not classify them as cancer, however, recognizing that they can potentially become cancer. Others classify certain types as a non-invasive form of cancer. The term "pre-cancer" has also been used.

<span class="mw-page-title-main">Mohs surgery</span> Surgery used to treat skin cancers

Mohs surgery, developed in 1938 by a general surgeon, Frederic E. Mohs, is microscopically controlled surgery used to treat both common and rare types of skin cancer. During the surgery, after each removal of tissue and while the patient waits, the tissue is examined for cancer cells. That examination dictates the decision for additional tissue removal. Mohs surgery is the gold standard method for obtaining complete margin control during removal of a skin cancer using frozen section histology. CCPDMA or Mohs surgery allows for the removal of a skin cancer with very narrow surgical margin and a high cure rate.

<span class="mw-page-title-main">Verrucous carcinoma</span> Medical condition

Verrucous carcinoma (VC) is an uncommon variant of squamous cell carcinoma. This form of cancer is often seen in those who chew tobacco or use snuff orally, so much so that it is sometimes referred to as "Snuff dipper's cancer".

p16 Mammalian protein found in Homo sapiens

p16, is a protein that slows cell division by slowing the progression of the cell cycle from the G1 phase to the S phase, thereby acting as a tumor suppressor. It is encoded by the CDKN2A gene. A deletion in this gene can result in insufficient or non-functional p16, accelerating the cell cycle and resulting in many types of cancer.

<span class="mw-page-title-main">Resection margin</span>

A resection margin or surgical margin is the margin of apparently non-tumorous tissue around a tumor that has been surgically removed, called "resected", in surgical oncology. The resection is an attempt to remove a cancer tumor so that no portion of the malignant growth extends past the edges or margin of the removed tumor and surrounding tissue. These are retained after the surgery and examined microscopically by a pathologist to see if the margin is indeed free from tumor cells. If cancerous cells are found at the edges the operation is much less likely to achieve the desired results.

<span class="mw-page-title-main">HPV-positive oropharyngeal cancer</span> Cancer of the throat

Human papillomavirus-positive oropharyngeal cancer, is a cancer of the throat caused by the human papillomavirus type 16 virus (HPV16). In the past, cancer of the oropharynx (throat) was associated with the use of alcohol or tobacco or both, but the majority of cases are now associated with the HPV virus, acquired by having oral contact with the genitals of a person who has a genital HPV infection. Risk factors include having a large number of sexual partners, a history of oral-genital sex or anal–oral sex, having a female partner with a history of either an abnormal Pap smear or cervical dysplasia, having chronic periodontitis, and, among men, younger age at first intercourse and a history of genital warts. HPV-positive OPC is considered a separate disease from HPV-negative oropharyngeal cancer.

Targeted therapy of lung cancer refers to using agents specifically designed to selectively target molecular pathways responsible for, or that substantially drive, the malignant phenotype of lung cancer cells, and as a consequence of this (relative) selectivity, cause fewer toxic effects on normal cells.

<span class="mw-page-title-main">Wolfram Samlowski</span> Oncologist

Wolfram Samlowski is an American medical oncologist with Comprehensive Cancer Centers of Nevada (CCCN) and a member of the Research Developmental Therapeutics and Genitourinary Committees for US Oncology. His research interests include translational research and development of novel cancer immunotherapy agents, translational drug development as well as gene therapy. His clinical interests are in developing more effective treatments for advanced stages of melanoma and non-melanoma skin cancers, and renal cancer.

In molecular biology mir-504 microRNA is a short RNA molecule. MicroRNAs function to regulate the expression levels of other genes by several mechanisms.

<span class="mw-page-title-main">Squamous-cell carcinoma of the lung</span> Medical condition

Squamous-cell carcinoma (SCC) of the lung is a histologic type of non-small-cell lung carcinoma (NSCLC). It is the second most prevalent type of lung cancer after lung adenocarcinoma and it originates in the bronchi. Its tumor cells are characterized by a squamous appearance, similar to the one observed in epidermal cells. Squamous-cell carcinoma of the lung is strongly associated with tobacco smoking, more than any other forms of NSCLC.

Rajesh Kumar Grover is an Indian oncologist and former director and chief executive officer of Delhi State Cancer Institute, New Delhi. The Government of India honoured him, in 2014, with the award of Padma Shri, the fourth highest civilian award, for his contributions to the field of medicine.

<span class="mw-page-title-main">Squamous-cell carcinoma</span> Carcinoma that derives from squamous epithelial cells

Squamous-cell carcinoma (SCC), also known as epidermoid carcinoma, comprises a number of different types of cancer that begin in squamous cells. These cells form on the surface of the skin, on the lining of hollow organs in the body, and on the lining of the respiratory and digestive tracts.

<span class="mw-page-title-main">Sandeep Nayak</span>

Sandeep Nayak is an Indian surgical oncologist based in Bangalore, India, known as the pioneer of robotic thyroidectomy technique called RABIT and Minimally Invasive Neck Dissection. He is the founder of MACS Clinic, Bangalore. He is the Senior Director and the Head of Department of surgical oncology at Fortis Hospital, Bangalore. Nayak was recipient of the KS International Innovation Award for his technique of RIA-MIND and Times Health Excellence Award for 2018 by The Times of India. Nayak is the member of Royal College of Surgeons of Edinburgh and American Society of Clinical Oncology. He has previously held the position of the assistant professor at Kidwai Memorial Institute of Oncology from 2012 to 2017. Nayak has been constantly ranked among the top oncologists in India.

Somashekhar SP is an Indian robotic surgeon, author and chairman of medical advisory board at Aster DM Healthcare - GCC & India. He is also the global director of Aster International Institute of Oncology in GCC & India. He is the president of the Association of Breast Surgeons of India, editor in chief of the IJGO Springer Indian Journal of Gynec Oncology and council member of The Association of Surgeons of India. He is also the editor of Annals of Breast Diseases.

<span class="mw-page-title-main">Ovarian squamous cell carcinoma</span> Medical condition

Ovarian squamous cell carcinoma (oSCC) or squamous ovarian carcinoma (SOC) is a rare tumor that accounts for 1% of ovarian cancers. Included in the World Health Organization's classification of ovarian cancer, it mainly affects women above 45 years of age. Survival depends on how advanced the disease is and how different or similar the individual cancer cells are.

References

  1. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 "Ambuja profile" . Retrieved 25 July 2014.
  2. 1 2 3 4 5 6 7 8 9 "Title unknown". The Hindu . 1 July 2008. Archived from the original on 5 July 2008. Retrieved 25 July 2014.
  3. Edgar Thorpe (2010). The Pearson Current Events Digest 2010. Delhi: Pearson Education India. p. 136. ISBN   9788131732922.
  4. 1 2 3 4 5 "Bio". Archived from the original on 28 July 2014. Retrieved 25 July 2014.
  5. "HCG" . Retrieved 25 July 2014.
  6. "Ambuja home" . Retrieved 25 July 2014.
  7. "Yoga" . Retrieved 25 July 2014.
  8. "Pubmed articles" . Retrieved 25 July 2014.
  9. KS Gopinath; AK Kattepur (May 2014). "Images in clinical medicine. Metastasis from thyroid carcinoma". New England Journal of Medicine. 371 (9): 867–874. doi: 10.1056/NEJMsr1406753 . PMID   25054609. S2CID   3637554.
  10. Rather MI, Swamy S, Gopinath KS, Kumar A (January 2014). "Transcriptional repression of tumor suppressor CDC73, encoding an RNA polymerase II interactor, by Wilms tumor 1 protein (WT1) promotes cell proliferation: implication for cancer therapeutics". The Journal of Biological Chemistry. 289 (2): 968–76. doi: 10.1074/jbc.M113.483255 . PMC   3887219 . PMID   24257751.
  11. Venkatesh T, Nagashri MN, Swamy SS, Mohiyuddin SM, Gopinath KS, Kumar (2013). "Primary microcephaly gene MCPH1 shows signatures of tumor suppressors and is regulated by miR-27a in oral squamous cell carcinoma". PLOS ONE. 8 (3): e54643. Bibcode:2013PLoSO...854643V. doi: 10.1371/journal.pone.0054643 . PMC   3589425 . PMID   23472065.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  12. Rather MI, Nagashri MN, Swamy SS, Gopinath KS, Kumar A (January 2014). "Oncogenic microRNA-155 down-regulates tumor suppressor CDC73 and promotes oral squamous cell carcinoma cell proliferation: implications for cancer therapeutics". The Journal of Biological Chemistry. 288 (1): 608–18. doi: 10.1074/jbc.M112.425736 . PMC   3537059 . PMID   23166327.
  13. Rather MI, Nagashri MN, Swamy SS, Gopinath KS, Kumar A (June 2009). "Spontaneous expulsion of benign phyllodes". The Breast Journal. 15 (3): 309. doi: 10.1111/j.1524-4741.2009.00726.x . PMID   19645792. S2CID   40570877.
  14. Banerjee B, Vadiraj HS, Ram A, Rao R, Jayapal M, Gopinath KS, Ramesh BS, Rao N, Kumar A, Raghuram N, Hegde S, Nagendra HR, Prakash Hande M (September 2007). "Effects of an integrated yoga program in modulating psychological stress and radiation-induced genotoxic stress in breast cancer patients undergoing radiotherapy". New England Journal of Medicine. 6 (3): 242–50. doi: 10.1177/1534735407306214 . PMID   17761637.